Efficacy of Ferric derisomaltose in chronic heart failure complicated with iron deficiency anaemia.

Efficacy of Ferric derisomaltose in chronic heart failure complicated with iron deficiency anaemia. - Efficacy of Ferric derisomaltose in chronic heart failure complicated with iron deficiency anaemia.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000053957

Enrollment

Registered

2024-03-24

Start date

2023-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with chronic heart failure complicated by iron deficiency anemia on oral iron therapy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with chronic heart failure complicated by iron deficiency anemia on oral iron therapy Hb<10g/dl

Exclusion criteria

Exclusion criteria: Patients who were deemed not appropriate to participate in this study by doctor

Design outcomes

Primary

Measure	Time frame
hemoglobin	—

Secondary

Measure	Time frame
Hematocrit, serum iron, ferritin, TSAT, NTProBNP, BNP, ANP, eGFR, P	—

Countries

Japan

Contacts

Public ContactMitsue Akiyama

Sekino Laboratory Department of Research

skn-np@sekino-hospital.com03-3986-5501

Outcome results